ENMD-2076
6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine
Molecular Identity
ENMD-2076
6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amine
PubChem CID: 16041424
2D Structure
Properties
C21H25N7
Molecular Formula
375.50
Molecular Weight
g/mol
375.2171
Exact Mass
Da
3.7
XLogP
Drug-like (Lipinski: < 5)
73
TPSA
Good oral absorption (< 140 A²)
2
H-Bond Donors
6
H-Bond Acceptors
499
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
ENMD-2076934353-76-1ENMD 20766-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]pyrimidin-4-amineENMD2076DTXSID602394304-Pyrimidinamine, 6-(4-methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-((1E)-2-phenylethenyl)-6-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-((E)-2-phenylethenyl)pyrimidin-4-amineRefChem:136939DTXCID801619214-Pyrimidinamine, 6-(4-methyl-1-piperazinyl)-N-(5-methyl-1H-pyrazol-3-yl)-2-((1E)-2-phenylethenyl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)KXQ762CQTHL-(+) Tartrate salt of ENMD-981693(E)-N-(5-Methyl-1H-pyrazol-3-yl)-6-(4-methylpiperazin-1-yl)-2-styrylpyrimidin-4-amineENMD-981693
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to ENMD-2076
Loading drug network...